When used as medication, GLP-1 RAs increase insulin production when blood sugar is high, reduce the amount of glucagon (a hormone that raises blood sugar), slow digestion, and increase feelings of fullness
Exenatide effects on cardiometabolic risk and weight in adolescents with morbid obesity and type 2 diabetes mellitus: two case reports
Patients in the UK seeking weight management support should consult their GP or an NHS specialist obesity service, where NICE-recommended options such as semaglutide (Wegovy) and tirzepatide (Zepbound) are currently available
Retatrutide is a synthetic peptide molecule engineered to activate three important hormone receptors involved in metabolism: GIP Receptor Activity Studied for its role in: Glucose-dependent insulin signaling Nutrient metabolism Hormonal regulation GLP-1 Receptor Activity Studied for its role in: Appetite signaling Satiety response Gastric emptying regulation Glucose control Glucagon Receptor Activity Studied for its role in: Energy expenditure Metabolic activity Fat utilization pathways Retatrutides triple-receptor design distinguishes it from singlepathway and dual-pathway metabolic peptides currently being researched
And, while the studies may not be as comprehensive as those of their pharmaceutical counterparts, its likely that the touted benefits of some of these supplements are not exclusively the result of a collective placebo effect
But retatrutide-specific human data is still limited, and it should not be viewed as a treatment for alcohol use disorder unless a qualified medical professional is specifically managing that care
